ViaDerma Inc (VDRM)

[Avoid]

In a press release this week, Viaderma Inc shared that several patients have had significant treatment success with the use of its innovative transdermal system for the delivery of its FDA registered drug, Viabecline. This is a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that can convert oral medication active ingredients into topical drugs and is registered as a first aid antibiotic to help prevent skin infection in minor cuts, scrapes, and burns.
The results were achieved in just 10 days of treatment using the company’s proprietary patent-pending transdermal delivery system, which can deliver medications and nutrients into the body through the skin and increase the absorption as much as 100 times directly to the localized treatment areas.

VDRM